Multiple endocrine neoplasia type 1 primary prevention: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
|||
Line 2: | Line 2: | ||
{{Multiple endocrine neoplasia type 1}} | {{Multiple endocrine neoplasia type 1}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== |
Revision as of 20:50, 17 October 2017
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 primary prevention On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 primary prevention |
FDA on Multiple endocrine neoplasia type 1 primary prevention |
CDC on Multiple endocrine neoplasia type 1 primary prevention |
Multiple endocrine neoplasia type 1 primary prevention in the news |
Blogs on Multiple endocrine neoplasia type 1 primary prevention |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is no established method for prevention of Multiple endocrine neoplasia-1 (MEN-1)
Primary Prevention
There is no established method for the prevention of the MEN-1